Yeungnam University Hospital
Daegu, 42127, South Korea
NCT Number: NCT04640220
The prevalence of shoulder joint disease is high in breast cancer patients. The cause of adhesive capsulitis is not clearly identified. However, the following are known as relevant factors that are the restriction of the use of the arm after surgery, inflammation due to autoimmune action, radiation therapy, and adhesion of the surgical site. The purpose of this study is to compare and analyze the effect of intrathecal steroid injection in breast cancer survivors with adhesive capsulitis.
Looking for future studies?
Notify MeFemale
Interventional
Not applicable
Daegu, 42127, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ultrasound-guided Gleno-humeral joint steroid (Triamcinolone 40mg with 0.5% lidocaine ) injection
Time frame: Change from baseline at 3 months
A goniometer is an instrument which measures the available range of motion at a joint.Flexion, Extension,Adduction,Abduction, Internal Rotation,External rotation
Time frame: Change from baseline at 3 months
SPADI is a scale consisting of 0-10; 0 being the best and 10 being the worse pain ever; higher scores mean a worse outcome.
Time frame: Change from baseline at 3 months
Ultrasound measurements of axillary recess capsule thickness in unilateral frozen shoulder
Yeungnam University Hospital
Other
The Effectiveness of Intra-articular Steroid Injection in Breast Cancer Survivors With Adhesive Capsulitis According to the Thickness of Axillary Capsulitis Thickness
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04489173
Breast Diseases, Breast Neoplasm
Arnhem, Netherlands
View Trial DetailsNCT03935282
Behavior, Breast Diseases
Fort Smith, Arkansas, United States
View Trial DetailsNCT03328026
Breast Cancer, Breast Cancer Metastatic
Newport Beach, California, United States
View Trial DetailsNCT06100068
Breast Diseases, Breast Neoplasm
Ghent, Belgium
View Trial Details